| 0.3509 0.09 (34.7%) | 12-08 15:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.49 | 1-year : | 0.64 |
| Resists | First : | 0.42 | Second : | 0.55 |
| Pivot price | 0.29 |
|||
| Supports | First : | 0.21 | Second : | 0.18 |
| MAs | MA(5) : | 0.29 |
MA(20) : | 0.28 |
| MA(100) : | 0.36  |
MA(250) : | 2.36 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 19.1 |
D(3) : | 15.6 |
| RSI | RSI(14): 60.1 |
|||
| 52-week | High : | 8.93 | Low : | 0.2 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ IONM ] has closed below upper band by 1.8%. Bollinger Bands are 35.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.37 - 0.37 | 0.37 - 0.37 |
| Low: | 0.26 - 0.26 | 0.26 - 0.26 |
| Close: | 0.35 - 0.35 | 0.35 - 0.36 |
Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. The company has operations in Arizona, Colorado, Kansas, Louisiana, Michigan, Missouri, Nebraska, Nevada, Pennsylvania, South Carolina, Texas, and Utah, the United States. Assure Holdings Corp. is based in Englewood, Colorado.
Tue, 28 Nov 2023
Assure Holdings Announces Receipt of Notice of Late Filing from Nasdaq - Financial Post
Thu, 02 Nov 2023
Assure Holdings Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement - Financial Post
Tue, 19 Sep 2023
Assure Holdings Corp. Announces Exploration of Strategic Alternatives - OrthoSpineNews
Mon, 26 Jun 2023
Assure Holdings Signs Letter of Intent to Purchase Certain Assets of Innovation Neuromonitoring, LLC - OrthoSpineNews
Fri, 14 Oct 2022
Assure Holdings Performs First Neuromonitoring Case in New Jersey - OrthoSpineNews
Tue, 09 Aug 2022
Assure Holdings Sets Second Quarter 2022 Conference Call for Monday, August 15, 2022, at 4:30 p.m. ET - Financial Post
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical Care Facilities
|
|
| Shares Out | 7 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 18.4 (%) |
| Held by Institutions | 4.8 (%) |
| Shares Short | 371 (K) |
| Shares Short P.Month | 241 (K) |
| EPS | -33.39 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.25 |
| Profit Margin | 0 % |
| Operating Margin | -354.2 % |
| Return on Assets (ttm) | -46.6 % |
| Return on Equity (ttm) | -274.6 % |
| Qtrly Rev. Growth | -6.2 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1.44 |
| EBITDA (p.s.) | -2.85 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -8 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | -0.02 |
| PEG Ratio | 0 |
| Price to Book value | 1.4 |
| Price to Sales | 0.24 |
| Price to Cash Flow | -0.29 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|